It takes a lot of infrastructure, and money, to build the giant bioreactors experts say are needed to mass produce raw materials needed to make things like medicine, vaccines and cultivated meat.
Matt Anderson-Baron, co-founder and CEO of Canada-based Future Fields, told TechCrunch that 10 billion liters of bioreactor capacity will be needed by 2030, yet only 61 million liters of it exists today.
In addition, the recombinant protein, which is the output of the bioreactors, accounts for the majority of the costs associated with producing cultivated meat and is partly why that sector has not bee
コメント